Indication
Diabetic Neuropathy Peripheral
2 clinical trials
4 products
Clinical trial
Clinical Study to Investigate the Possible Effect of Empagliflozin in Treatment of Peripheral Diabetic Neuropathy in Patients With Diabetes Mellitus Type 2Status: Completed, Estimated PCD: 2023-08-01
Product
EmpagliflozinClinical trial
A 3-arm, Open-label, Stratified Randomized Controlled Trial With Blinded End-point Assessment to EValuate A Nitric oxidE Generator (Nebivolol) as a diSease Modifying mediCatioN in Diabetic Peripheral NeuropathyStatus: Not yet recruiting, Estimated PCD: 2025-12-30
Product
Nebivolol+ Standard careProduct
Standard care alone